Atlas Trials

DaxibotulinumtoxinA Injection for Treatment of Adductor Spasmodic Dysphonia

Clinical trial NCT05158166 · COMPLETED

Trial details

NCT number
NCT05158166
Sponsor
University of California, San Francisco
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Adductor Spasmodic DysphoniaVoice DisordersSpasmodic Dysphonia
Start date
2023-10-13
Primary completion
2025-03-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.